Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
Brief Summary: This is a prospective study to evaluate effect of Exenatide extended release treatment for 1 year on albuminuria levels in T2DM patients with micro- and macroalbuminuria compared to placebo.